A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs

BMC Musculoskeletal Disorders

Adam Young¹  John Done²  Lyndsay D Hughes² 

[1] Department of Rheumatology, St Alban’s City Hospital, Waverley Road, St Albans, Hertfordshire AL3 5PN, England;Centre for Lifespan and Chronic Illness Research (CLiCIR), University of Hertfordshire, Health Research Building, College Lane, Hatfield AL10 9AB, England

关键词: Factor analysis;    Questionnaire;    Compliance;    Medication adherence;    DMARDs;    Rheumatoid arthritis;   

Others  :  1129531
DOI  :  10.1186/1471-2474-14-286

 received in 2013-01-16, accepted in 2013-09-25,  发布年份 2013

【 摘 要 】

Background

Taking DMARDs as prescribed is an essential part of self-management for patients with Rheumatoid Arthritis. To date, the Compliance Questionnaire for Rheumatology (CQR) is the only self-report adherence measure created specifically for and validated in rheumatic diseases. However, the factor structure of the CQR has not been reported and it can be considered lengthy at 19 items. The aim of this study was to test the factor structure of the CQR and reduce the number of items whilst retaining robust explanation of non-adherence to DMARDs. Such a reduction would increase the clinical utility of the scale, to identify patients with sub-optimal adherence to DMARDs in the clinic as well as for research purposes.

Methods

An exploratory factor analysis was performed to reduce the number of items in the CQR and then a confirmatory factor analysis was run to establish the fit of a 5 item version (CQR5) to the data. A discriminant function analysis was performed to determine the optimal combination of questions to identify suboptimal adherence.

Results

The factor analyses identified a unidimensional 5 item model that explains 50.3% of the variance in adherence and has good internal consistency and fit to the data. Discriminant function analysis shows that the CQR5 can affectively detect 69% of low adherers to DMARDs using Fisher’s weighted regression equation.

Conclusion

A shortened version of the CQR increases the clinical utility by reducing the patient burden whilst maintaining a good level of reliability and validity for a short, self-administered, self-report questionnaire.

【 授权许可】

   
2013 Hughes et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]ten Wolde S, Breedveld FC, Dijkmans BAC, Hermans J, Vandenbroucke JP, van de Laar MAFJ, et al.: Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (British edition) 1996, 347(8998):347-352.
• [2]Park DC, Hertzog C, Leventhal H, Morrell RW, Leventhal E, Birchmore D, et al.: Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc 1999, 47:172-183.
• [3]Young A: Current approached to drug treatment in rheumatoid arthritis. Prescriber 2008, 19:19-28.
• [4]Goodacre LJ, Goodacre JA: Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology 2004, 43(5):583-586.
• [5]Treharne GJ, Lyons AC, Hale ED, Douglas KMJ, Kitas GD: ‘Compliance’ is futile but is ‘concordance’ between rheumatology patients and health professionals attainable? Rheumatology 2006, 45:1-5.
• [6]Grijalva CG, Chung CP, Arbogast PG, Stein CM, Mitchel EF Jr, Griffin MR: Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Med Care 2007, 45(10):S66.
• [7]DiMatteo MR: Enhancing patient adherence to medical recommendations. JAMA 1994, 271(1):79.
• [8]Hughes DA, Bagust A, Haycox A, Walley T: The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ 2001, 10:601-615.
• [9]Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997, 50(1):105-116.
• [10]Barber N, Parsons J, Clifford S, Dattacott R, Horne R: Patients’ problems with new medication for chronic conditions. QSHC 2004, 13:172-175.
• [11]Viller F, Guillemin F, Briancon S, Moum T, Suurmeijer T, van den Heuvel W: Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 1999, 26(10):2114-2122.
• [12]de Klerk E, van der Heijde D, Landewe R, van der Tempel H, van der Linden S: The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol 2003, 30(11):2469-2475.
• [13]Garber MC, Nau DP, Erikson SR, Aikens JE, Lawrence JB: The concordance of self report with other measures of medication adherence. a summary of the literature. Med Care 2004, 42(7):649-652.
• [14]Neame R, Hammond A: Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology 2005, 44:762-767.
• [15]de Klerk E, van der Heijde D, van der Tempel H, van der Linden S: Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol 1999, 26(12):2635-2641.
• [16]Brown TA: Confirmatory Factor Analysis for Applied Research. New York: Guildford Press; 2006.
• [17]Tabachnik BGF, Fidell LS: Using Multivariate Statistics. New York: Harper Collins; 1989.
• [18]Kolenikov S: Confirmatory factor analysis using cfa. Stata J 2009, 9(3):1-44.
• [19]MacCallum RC, Widaman KF, Zhang S, Hong S: Sample size in factor analysis. Psychol Methods 1999, 4:84-99.
• [20]Kaiser H: An index of factorial simplicity. Psychometrika 1974, 39:31-36.
• [21]Hu L, Bentler PM: Cut-off criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equn Modeling 1999, 6(1):1-55.
• [22]Horne R, Weinman J, Hankins M: The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 14(1):1-24.
• [23]Treharne GJ, Lyons AC, Kitas GD: Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med 2004, 9(3):337-349.
• [24]Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron LD, Buick D: The revised illness perceptions questionnaire (IPQ-R). Psychol Health 2002, 17(1):1-16.
• [25]de Thurah A, Norgaard M, Harder I, Stengaard-Petersen K: Compliance with Methotrexate treatment in patients with rheumatoid arthritis: influence of patients’ beliefs about the medicine. a prospective cohort study. Rheumatol Int 2010, 30:1441-1448.
• [26]Hughes LD: Psychological Adjustment to the Onset of Rheumatoid Arthritis: a Longitudinal Evaluation of Perceptions of and Adherence to Medication. PhD thesis. University of Hertfordshire, School of Psychology; 2011.
• [27]Treharne GJ, Lyons AC, Hale ED, Douglas KMJ, Kitas GD: Predictors of medication adherence in people with rheumatoid arthritis: studies are necessary but non-validated measures of medication adherence are of concern. Rheumatology 2005, 44(10):1330.